We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ENLV market cap is 25.6M. The company's latest EPS is USD -1.6862 and P/E is -0.85.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.68M | -7.85M | -6.78M | -6.65M | -5.63M |
| Net Income | -5.73M | -7.19M | -7.22M | -6.79M | -5.96M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -5.3M | -8.62M | -9.79M | -19.29M | -25.8M |
| Net Income | -4.24M | -9.38M | -11.82M | -14.47M | -31.06M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 72.41M | 67.64M | 60.02M | 53.03M | 46.94M |
| Total Liabilities | 9.14M | 10.8M | 9.45M | 8.69M | 8.16M |
| Total Equity | 63.27M | 56.84M | 50.57M | 44.34M | 38.78M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 11.03M | 17.56M | 40.36M | 95.15M | 67.64M |
| Total Liabilities | 1.33M | 6.28M | 4.87M | 10.11M | 10.8M |
| Total Equity | 9.71M | 11.28M | 35.49M | 85.04M | 56.84M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.14M | -23.95M | -5.78M | -12.81M | -18.25M |
| Investing | 65.4M | 62.52M | -31.35M | -34.05M | -30.1M |
| Financing | 150k | 150k | 318k | 360k | 360k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.16M | -7.04M | -11.01M | -17.54M | -23.95M |
| Investing | -533k | -6.36M | -20.98M | -38.41M | 62.52M |
| Financing | 5.19M | 8.31M | 33.08M | 60.98M | 150k |
| Market Cap | 25.6M |
| Price to Earnings Ratio | -0.85 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.53 |
| Price to Book Ratio | 0.46 |
| Dividend Yield | - |
| Shares Outstanding | 18.42M |
| Average Volume (1 week) | 1.1M |
| Average Volume (1 Month) | 387.34k |
| 52 Week Change | -51.23% |
| 52 Week High | 4.59 |
| 52 Week Low | 1.15 |
| Spread (Intraday) | 0.02 (1.42%) |
| Company Name | Enlivex Therapeutics Ltd |
| Address |
14 einstein street ness ziona, center 7403618 |
| Website | https://www.enlivex.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
